Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification

Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification

IdentiClone® Dx IGH is the first IVDR-certified assay for the detection of clonal immunoglobulin gene rearrangements in patients with suspected B-cell lymphoproliferative disease. SAN DIEGO — Invivoscribe, a global leader in precision diagnostics and measurab…

IdentiClone® Dx IGH is the first IVDR-certified assay for the detection of clonal immunoglobulin gene rearrangements in patients with suspected B-cell lymphoproliferative disease. THIS CONTENT IS RE… [+5964 chars]